Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
GJ Netto - Nature Reviews Urology, 2012 - nature.com
The unprecedented advances in cancer genetics and genomics are rapidly affecting the
clinical management of solid tumors. Molecular diagnostics are now an integral part of …
clinical management of solid tumors. Molecular diagnostics are now an integral part of …
Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
GJ Netto - Nature reviews. Urology, 2011 - pubmed.ncbi.nlm.nih.gov
The unprecedented advances in cancer genetics and genomics are rapidly affecting the
clinical management of solid tumors. Molecular diagnostics are now an integral part of …
clinical management of solid tumors. Molecular diagnostics are now an integral part of …
Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
GJ Netto - Nature Reviews Urology, 2012 - go.gale.com
The unprecedented advances in cancer genetics and genomics are rapidly affecting the
clinical management of solid tumors. Molecular diagnostics are now an integral part of …
clinical management of solid tumors. Molecular diagnostics are now an integral part of …
[PDF][PDF] Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
GJ Netto - 2011 - academia.edu
The unprecedented advances in cancer genetics and genomics are rapidly affecting the
clinical management of solid tumors. Molecular diagnostics are now an integral part of …
clinical management of solid tumors. Molecular diagnostics are now an integral part of …
Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
GJ Netto - Nature, 2012 - hero.epa.gov
The unprecedented advances in cancer genetics and genomics are rapidly affecting the
clinical management of solid tumors. Molecular diagnostics are now an integral part of …
clinical management of solid tumors. Molecular diagnostics are now an integral part of …
Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
GJ Netto - Nature Reviews. Urology, 2012 - search.proquest.com
The unprecedented advances in cancer genetics and genomics are rapidly affecting the
clinical management of solid tumors. Molecular diagnostics are now an integral part of …
clinical management of solid tumors. Molecular diagnostics are now an integral part of …
Molecular biomarkers in urothelial carcinoma of the bladder: Are we there yet?
GJ Netto - Nature Reviews Urology, 2012 - pure.johnshopkins.edu
The unprecedented advances in cancer genetics and genomics are rapidly affecting the
clinical management of solid tumors. Molecular diagnostics are now an integral part of …
clinical management of solid tumors. Molecular diagnostics are now an integral part of …
Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
GJ Netto - Nature reviews. Urology, 2011 - europepmc.org
The unprecedented advances in cancer genetics and genomics are rapidly affecting the
clinical management of solid tumors. Molecular diagnostics are now an integral part of …
clinical management of solid tumors. Molecular diagnostics are now an integral part of …